You are here

Awakn Life Sciences Corp.

Awakn Life Sciences Corp.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
AWKN
CSE Index: 
Currency: 

Awakn Life Sciences Corp. is a clinical-stage biotechnology company developing medication-assisted treatments for addiction. Awakn has a near-term focus on Alcohol Use Disorder (AUD), a condition affecting approximately 51 million people in the US and key European markets and 285 million people globally for which the current standard of care is inadequate. Our goal is to provide breakthrough therapeutics to addiction sufferers in desperate need and our strategy is focused on commercializing our R&D pipeline across multiple channels.

You are here

Awakn Life Sciences Corp. (AWKN)

SEDAR Information

Company Info

Address
301,217 Queen St W.
Toronto, ON M5V 0R2
Canada
Phone
(416) 270-9566
Email
Jonathanh@awaknlifesciences.com
Website
https://www.awaknlifesciences.com
Listing date
Tuesday, February 13, 2024
Transfer Agent
Endeavor Trust Corporation
Investor Relations
Anthony Tennyson
Email
Anthony.tennyson@awaknlifesciences.com
Auditor
MNP LLP

Capitalization

Issued & Outstanding: 
41662623
Reserved for Issuance: 
18983178

Company Officers

Anthony Tennyson, CEO
Jonathan Held, CFO / CBO
Prof. David Nutt, Chief Research Officer

Bulletins

31/05/2024

2024-0530 - Reinstatement - Awakn Life Sciences Corp. (AWKN)

le 31 mai/May 2024

Effective immediately, Awakn Life Sciences Corp. will be reinstated for trading.

The Company has rectified the situation that gave rise to the suspension.

____________________________

Avec effet immédiat, Awakn Life Sciences Corp. sera réintégrée à la négociation.

La Société a rectifié la situation qui a donné lieu à la suspension.